Literature DB >> 19751276

The elevated interferon gamma production is an important immunological marker in HAM/TSP pathogenesis.

P A Montanheiro1, A C Penalva de Oliveira, J Smid, L M I Fukumori, I Olah, A J da S Duarte, J Casseb.   

Abstract

Human T-lymphotropic virus type 1 (HTLV-1) is the agent of the HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP), which may occur in >5% of patients during their lifetime. HTLV-1-infection causes disturbances in the immune system, and the viral load may also play an important role in the pathogenesis of HAM/TSP. Some cytokines are involved in the pathogenesis of this disorder. We have determined IL-2, IL-4, IL-10, IL-12 p70, IFN-gamma and TNF-alpha production among HTLV-1-infected subjects from our HTLV-out Clinic in Institute of Infectious 'Emílio Ribas' in Sao Paulo city, Brazil. PBMC obtained from healthy controls (n = 32), asymptomatic HTLV-1 carriers (n = 68) and HAM/TSP patients (n = 44) were grown in the absence and in the presence of phytohaemagglutinin (PHA), and the supernatants' fluids were measured for cytokines production. IL-2 levels were increased in the asymptomatic HTLV-1 carriers, and IFN-gamma was increased in both groups of patients (asymptomatic HTLV-1 carriers and more significantly among HAM/TSP patients). IL-4, IL-10, TNF-alpha and IL-12 p70 levels were not significantly increased on both groups of patients, as compared with controls. The major finding of this study is that IFN-gamma was an important cytokine for the HAM/TSP pathogenesis. Therefore, immune modulation of IFN-gamma may be critical to treat of HAM/TSP patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19751276     DOI: 10.1111/j.1365-3083.2009.02291.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  17 in total

1.  Neurological manifestations in individuals with HTLV-1-associated myelopathy/tropical spastic paraparesis in the Amazon.

Authors:  G A S Dias; G T Yoshikawa; R V L Koyama; S Fujihara; L C S Martins; R Medeiros; J A S Quaresma; H T Fuzii
Journal:  Spinal Cord       Date:  2015-07-14       Impact factor: 2.772

2.  Constitutive release of IFNγ and IL2 from peripheral blood mononuclear cells of rhesus macaques (Macaca mulatta) infected with simian T-lymphotropic virus type 1.

Authors:  JoAnn L Yee; Nestor A Montiel; Amir Ardeshir; Amir Ardeshr; Nicholas W Lerche
Journal:  Comp Med       Date:  2013       Impact factor: 0.982

3.  CD4+ T cell subsets and Tax expression in HTLV-1 associated diseases.

Authors:  Nicolas Barros; Jorge Risco; Carlos Rodríguez; Cesar Sánchez; Elsa González; Yuetsu Tanaka; Eduardo Gotuzzo; A Clinton White; Martin Montes
Journal:  Pathog Glob Health       Date:  2013-06       Impact factor: 2.894

Review 4.  Human T cell leukemia virus type 1 and Zika virus: tale of two reemerging viruses with neuropathological sequelae of public health concern.

Authors:  DeGaulle I Chigbu; Pooja Jain; Brenndan L Crumley; Dip Patel; Zafar K Khan
Journal:  J Neurovirol       Date:  2019-01-28       Impact factor: 3.739

5.  IL28B gene polymorphism SNP rs8099917 genotype GG is associated with HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in HTLV-1 carriers.

Authors:  Tatiane Assone; Fernando Vieira de Souza; Karen Oliveira Gaester; Luiz Augusto Marcondes Fonseca; Olinda do Carmo Luiz; Fernanda Malta; João Renato Rebello Pinho; Fernanda de Toledo Gonçalves; Alberto Jose da Silva Duarte; Augusto Cesar Penalva de Oliveira; Jorge Casseb
Journal:  PLoS Negl Trop Dis       Date:  2014-09-18

6.  Switching and loss of cellular cytokine producing capacity characterize in vivo viral infection and malignant transformation in human T- lymphotropic virus type 1 infection.

Authors:  Huseini Kagdi; Maria Antonietta Demontis; Juan Carlos Ramos; Graham P Taylor
Journal:  PLoS Pathog       Date:  2018-02-14       Impact factor: 6.823

7.  Cytokine profile and proviral load among Japanese immigrants and non-Japanese infected with HTLV-1 in a non-endemic area of Brazil.

Authors:  João Américo Domingos; Luana Silva Soares; Larissa M Bandeira; Camila Mareti Bonin; Ana C P Vicente; Louise Zanella; Marco Antonio Moreira Puga; Inês Aparecida Tozetti; Ana Rita Coimbra Motta-Castro; Rivaldo Venâncio da Cunha
Journal:  PLoS One       Date:  2017-04-04       Impact factor: 3.240

8.  Immunological profile of HTLV-1-infected patients associated with infectious or autoimmune dermatological disorders.

Authors:  Jordana Grazziela Alves Coelho-dos-Reis; Livia Passos; Mariana Costa Duarte; Marcelo Grossi Araújo; Ana Carolina Campi-Azevedo; Andréa Teixeira-Carvalho; Vanessa Peruhype-Magalhães; Bruno Caetano Trindade; Raquel Dos Santos Dias; Marina Lobato Martins; Anna Barbara de Freitas Carneiro-Proietti; Antônio Carlos Guedes; Denise Utsch Gonçalves; Olindo Assis Martins-Filho
Journal:  PLoS Negl Trop Dis       Date:  2013-07-25

9.  CD80+ and CD86+ B cells as biomarkers and possible therapeutic targets in HTLV-1 associated myelopathy/tropical spastic paraparesis and multiple sclerosis.

Authors:  Soraya Maria Menezes; Daniele Decanine; David Brassat; Ricardo Khouri; Saul V Schnitman; Ramon Kruschewsky; Giovanni López; Carolina Alvarez; Michael Talledo; Eduardo Gotuzzo; Anne-Mieke Vandamme; Bernardo Galvão-Castro; Roland Liblau; Johan Van Weyenbergh
Journal:  J Neuroinflammation       Date:  2014-01-29       Impact factor: 8.322

Review 10.  Genetic Markers of the Host in Persons Living with HTLV-1, HIV and HCV Infections.

Authors:  Tatiane Assone; Arthur Paiva; Luiz Augusto M Fonseca; Jorge Casseb
Journal:  Viruses       Date:  2016-02-03       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.